Health Catalyst Inc., a Salt Lake City provider of data and analytics software and service to the healthcare industry, has announced the closing of its initial public offering of 8,050,000 shares of common stock. The shares were sold to the public at $26 per share, the company said in a statement last week.
Health Catalyst said that the offering underwriters held an option to purchase 1.05 million additional shares of common stock and fully exercised the option, resulting in total gross proceeds of $209.3 million, before deducting underwriting discounts and commissions and other offering expenses payable by Health Catalyst.
Health Catalyst’s common stock began trading on the Nasdaq Global Select Market under the symbol HCAT on July 25.
Goldman Sachs, J.P. Morgan and William Blair acted as joint book-running managers for the offering as representatives of the underwriters. Piper Jaffray, Evercore ISI and SVB Leerink acted as passive book-running managers. SunTrust Robinson Humphrey acted as a co-manager for the IPO.
Health Catalyst provides cloud-based data and analytics technology and services to healthcare organizations. The company’s software currently handles more than 100 million patient records.